Page results
-
UCLH will play a vital role in a new respiratory virus study.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
File results
-
FOI/2023/0761 - Trust EPR system/ clinical data repository
-
FOI/2023/0767 - Insomnia treatment pathways
-
FOI/2023/0768 - Issues/ problems with Electronic Patient Records (EPR)
-
FOI/2023/0769 - Patients with Inflammatory Bowel Disease/ Small Intestinal Bacterial Overgrowth (SIBO)
-
FOI/2023/0776 - Electronic Patients Records System (EPRS)
-
FOI/2023/0777 - Number of patients treated for scurvy and ricketts
-
FOI/2023/0787 - HIMSS INFRAM assessment/ digital strategy
-
FOI/2023/0788 - Networking/ WiFi/ telephony hardware/ unified communications refresh
-
FOI/2023/0792 - Bank and agency strategy for the ICB
-
FOI/2023/0794 - Pandas/ PANS/ immune mediated neuro behaviour conditions